Literature DB >> 6705695

[Radical nature and life expectancy in the surgical treatment of esophageal and cardial carcinoma].

U Kunath, P Fischer.   

Abstract

Fifty-four patients with carcinoma of the oesophagus and cardia were selected to have either a two-cavity radical operation or blunt oesophagectomy without thoracotomy. Squamous-cell carcinomas were randomized for postoperative radiotherapy or none. Neither the two-cavity radical operation nor additional radiotherapy prolonged life expectancy. The results cast doubt on the effectiveness of local radical or curative surgery for carcinoma of the oesophagus and cardia. The only objective in the choice of treatment must be to decrease operative mortality and to make the course of the disease tolerable to the patient.

Entities:  

Mesh:

Year:  1984        PMID: 6705695     DOI: 10.1055/s-2008-1069212

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  10 in total

Review 1.  Neoadjuvant treatment of esophageal cancer.

Authors:  Nicholas P Campbell; Victoria M Villaflor
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

Review 2.  Perioperative therapy for esophageal cancer.

Authors:  Makoto Yamasaki; Hiroshi Miyata; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-29

3.  [Transmediastinal esophagectomy].

Authors:  J R Siewert; A H Hölscher; O P Horvath
Journal:  Langenbecks Arch Chir       Date:  1986

4.  [Advantages of left thoracic stomach interposition following esophagus resection for cancer].

Authors:  B Husemann
Journal:  Langenbecks Arch Chir       Date:  1985

Review 5.  Esophageal cancer management controversies: Radiation oncology point of view.

Authors:  Patricia Tai; Edward Yu
Journal:  World J Gastrointest Oncol       Date:  2014-08-15

6.  EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway.

Authors:  Rui Zhang; Dan Han; Lu Li; Wenguang Luo; Jing Liu; Liting Qian
Journal:  Cancer Manag Res       Date:  2020-10-02       Impact factor: 3.989

7.  Cancer of the distal esophagus and cardia. Incidence, tumorous infiltration, and metastatic spread.

Authors:  H U Sons; F Borchard
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

8.  Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.

Authors:  Yaping Xu; Jinshi Liu; Xianghui Du; Xiaojiang Sun; Yuanda Zheng; Jianxiang Chen; Bo Li; Wei Liu; Hao Jiang; Weimin Mao
Journal:  Radiat Oncol       Date:  2013-05-08       Impact factor: 3.481

9.  Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.

Authors:  Wenjie Ni; Shufei Yu; Zefen Xiao; Zongmei Zhou; Dongfu Chen; Qinfu Feng; Jun Liang; Jima Lv; Shugeng Gao; Yousheng Mao; Qi Xue; Kelin Sun; Xiangyang Liu; Dekang Fang; Jian Li; Dali Wang; Jun Zhao; Yushun Gao
Journal:  Oncologist       Date:  2021-08-19

Review 10.  Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

Authors:  Yaping Xu; Xinmin Yu; Qixun Chen; Weimin Mao
Journal:  World J Surg Oncol       Date:  2012-08-25       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.